Bisacodyl
- Generic Name
- Bisacodyl
- Brand Names
- Alophen Reformulated Jan 2008, Bi-peglyte, Bisac-evac, Carters Little Pills, Dulcolax, Fleet Mineral Oil, Gavilyte-H and Bisacodyl
- Drug Type
- Small Molecule
- Chemical Formula
- C22H19NO4
- CAS Number
- 603-50-9
- Unique Ingredient Identifier
- 10X0709Y6I
- Background
Bisacodyl, a diphenylmethane derivative, is a commonly used over the counter stimulant laxative for occasional constipation. Both bisacodyl and picosulfate are metabolized to the same active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).
Bisacodyl was patented on 25 September 1956 but has been used as a laxative since 1952.
- Indication
Bisacodyl is indicated to relieve occasional constipation and irregularity.
- Associated Conditions
- Bowel movement irregularity, Constipation, Occasional Constipation
- Associated Therapies
- Bowel preparation therapy
Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2014-01-20
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 285
- Registration Number
- NCT01011426
- Locations
- 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
Randomized Clinical Trial of Bisacodyl Versus Placebo on Postoperative Bowel Motility in Elective Colorectal Surgery
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2007-07-31
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Target Recruit Count
- 200
- Registration Number
- NCT00509327
- Locations
- 🇨🇭
Department of Surgery, Triemli Hospital, Zurich, Switzerland, Zurich, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath